AKAST Fundamental Analysis - AKASTOR ASA

Fundamental Rating

Overall AKAST gets a fundamental rating of 2 out of 10. We evaluated AKAST against 37 industry peers in the Energy Equipment & Services industry. While AKAST seems to be doing ok healthwise, there are quite some concerns on its profitability. AKAST is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

AKAST had negative earnings in the past year.

In the past year AKAST has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: AKAST reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: AKAST reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of AKAST (-0.93%) is worse than 83.78% of its industry peers.

AKAST has a worse Return On Equity (-1.06%) than 81.08% of its industry peers.

With a Return On Invested Capital value of 0.25%, AKAST is not doing good in the industry: 83.78% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-0.93%
ROE	-1.06%
ROIC	0.25%

ROA(3y)5.41%

ROA(5y)4.53%

ROE(3y)4.92%

ROE(5y)4.27%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of AKAST has grown nicely.

AKAST's Operating Margin of 5.52% is on the low side compared to the rest of the industry. AKAST is outperformed by 78.38% of its industry peers.

Looking at the Gross Margin, with a value of 27.91%, AKAST is in the better half of the industry, outperforming 64.86% of the companies in the same industry.

In the last couple of years the Gross Margin of AKAST has declined.

		Industry Rank	Sector Rank
OM	5.52%
PM (TTM)	N/A
GM	27.91%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y77.83%

PM growth 5Y213.61%

GM growth 3Y-21.44%

GM growth 5Y-8.67%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKAST is destroying value.

Compared to 1 year ago, AKAST has about the same amount of shares outstanding.

AKAST has more shares outstanding than it did 5 years ago.

The debt/assets ratio for AKAST has been reduced compared to a year ago.

2.2 Solvency

AKAST has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.

AKAST's Debt to Equity ratio of 0.04 is amongst the best of the industry. AKAST outperforms 89.19% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACC0.02

WACC10.46%

2.3 Liquidity

A Current Ratio of 2.19 indicates that AKAST has no problem at all paying its short term obligations.

AKAST has a better Current ratio (2.19) than 78.38% of its industry peers.

A Quick Ratio of 2.19 indicates that AKAST has no problem at all paying its short term obligations.

AKAST has a better Quick ratio (2.19) than 81.08% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.19
Quick Ratio	2.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AKAST have decreased strongly by -104.78% in the last year.

AKAST shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 75.95% yearly.

The Revenue for AKAST has decreased by -61.04% in the past year. This is quite bad

AKAST shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -44.12% yearly.

EPS 1Y (TTM)-104.78%

EPS 3Y21.55%

EPS 5Y75.95%

EPS Q2Q%-102.33%

Revenue 1Y (TTM)-61.04%

Revenue growth 3Y-31.61%

Revenue growth 5Y-44.12%

Sales Q2Q%-13.19%

3.2 Future

The Earnings Per Share is expected to decrease by -38.02% on average over the next years. This is quite bad

AKAST is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.85% yearly.

EPS Next Y-90.48%

EPS Next 2Y-51.2%

EPS Next 3Y-38.02%

EPS Next 5YN/A

Revenue Next Year-58.39%

Revenue Next 2Y-32.24%

Revenue Next 3Y-22.85%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKAST. In the last year negative earnings were reported.

With a Price/Forward Earnings ratio of 22.58, AKAST is valued on the expensive side.

Based on the Price/Forward Earnings ratio, AKAST is valued expensively inside the industry as 81.08% of the companies are valued cheaper.

Compared to an average S&P500 Price/Forward Earnings ratio of 22.59, AKAST is valued at the same level.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	22.58

4.2 Price Multiples

AKAST's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AKAST is more expensive than 78.38% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	48.07

4.3 Compensation for Growth

A cheap valuation may be justified as AKAST's earnings are expected to decrease with -38.02% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-51.2%

EPS Next 3Y-38.02%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AKAST does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AKASTOR ASA

OSL:AKAST (9/10/2025, 3:38:21 PM)

11.63

-0.05 (-0.43%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryEnergy Equipment & Services

Earnings (Last)07-10 2025-07-10

Earnings (Next)10-30 2025-10-30

Inst Owners17.34%

Inst Owner ChangeN/A

Ins Owners1.64%

Ins Owner ChangeN/A

Market Cap3.19B

Analysts86

Price Target20.4 (75.41%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-9.61%

Min Revenue beat(2)-13.82%

Max Revenue beat(2)-5.4%

Revenue beat(4)2

Avg Revenue beat(4)-2.08%

Min Revenue beat(4)-13.82%

Max Revenue beat(4)10.48%

Revenue beat(8)4

Avg Revenue beat(8)-3.02%

Revenue beat(12)5

Avg Revenue beat(12)-15.39%

Revenue beat(16)9

Avg Revenue beat(16)-8.29%

PT rev (1m)-4.76%

PT rev (3m)-4.76%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	22.58
P/S	9.26
P/FCF	N/A
P/OCF	N/A
P/B	0.58
P/tB	0.58
EV/EBITDA	48.07

EPS(TTM)-0.22

EYN/A

EPS(NY)0.52

Fwd EY4.43%

FCF(TTM)-0.22

FCFYN/A

OCF(TTM)-0.09

OCFYN/A

SpS1.26

BVpS19.95

TBVpS19.95

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.93%
ROE	-1.06%
ROCE	0.32%
ROIC	0.25%
ROICexc	0.26%
ROICexgc	0.26%
OM	5.52%
PM (TTM)	N/A
GM	27.91%
FCFM	N/A

ROA(3y)5.41%

ROA(5y)4.53%

ROE(3y)4.92%

ROE(5y)4.27%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y77.83%

PM growth 5Y213.61%

GM growth 3Y-21.44%

GM growth 5Y-8.67%

F-Score4

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	3.95
Cap/Depr	92.5%
Cap/Sales	10.76%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.19
Quick Ratio	2.19
Altman-Z	N/A

F-Score4

WACC10.46%

ROIC/WACC0.02

Cap/Depr(3y)202.64%

Cap/Depr(5y)136.86%

Cap/Sales(3y)20%

Cap/Sales(5y)16.61%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-104.78%

EPS 3Y21.55%

EPS 5Y75.95%

EPS Q2Q%-102.33%

EPS Next Y-90.48%

EPS Next 2Y-51.2%

EPS Next 3Y-38.02%

EPS Next 5YN/A

Revenue 1Y (TTM)-61.04%

Revenue growth 3Y-31.61%

Revenue growth 5Y-44.12%

Sales Q2Q%-13.19%

Revenue Next Year-58.39%

Revenue Next 2Y-32.24%

Revenue Next 3Y-22.85%

Revenue Next 5YN/A

EBIT growth 1Y-96.78%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-92.76%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y59.87%

FCF growth 3YN/A

FCF growth 5Y42.34%

OCF growth 1Y83.89%

OCF growth 3YN/A

OCF growth 5Y34.38%

AKASTOR ASA (AKAST.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens